Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05598398 · ClinicalTrials.gov registry record · Phase 4

NPWTi on Closure of Chronic Pressure Sores

A Phase 4 study of Pressure Sore, sponsored by Northwestern University.

Recruiting
Registry status
Phase 4
Development phase
62
Enrollment target
1
Study location

NCT05598398 is a Phase 4 study of Pressure Sore that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 62 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05598398, a Phase 4 study of Pressure Sore, is actively recruiting participants, sponsored by Northwestern University.

RECRUITING
Registry status
Phase 4
Development phase
62 participants
Enrollment target
1
Study location

Study Summary

The primary objective of this study is to assess the effectiveness of the Negative Pressure Wound Therapy system with instillation therapy (NPWTi) on closure of chronic pressure sores. This intervention will be compared to wet-to-dry dressings, which is standard of care. In this post-market, on-label study, we hope to show that the NPWTi system more effectively closes pressure sores following debridement than traditional care.

Conditions Studied

Interventions

  • DEVICE V.A.C.Ulta™ Negative Pressure Wound Therapy System
  • OTHER Standard of Care (Wet-to-dry dressings)

Study Locations (1)

Illinois

  • Northwestern University - Chicago

Trial Details

FieldValue
Enrollment Target 62 participants
Start Date 2022-09-26
Est. Completion 2025-10
Phase Phase 4

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT05598398

The ClinicalTrials.gov registry entry for NCT05598398 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pressure Sore appearing as the primary indexed condition, and to 2 interventions - of which V.A.C.Ulta™ Negative Pressure Wound Therapy System is the first listed.

NCT05598398 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT05598398 about?

NCT05598398 is a clinical study titled "NPWTi on Closure of Chronic Pressure Sores". The primary objective of this study is to assess the effectiveness of the Negative Pressure Wound Therapy system with instillation therapy (NPWTi) on closure of chronic pressure sores. This intervention will be compared to wet-to-dry dressings, which is standard of care. In this post-market, on-labe...

What is the current status of trial NCT05598398?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 62 participants. The study started on 2022-09-26. Estimated completion is 2025-10.

What conditions does trial NCT05598398 study?

This clinical trial studies the following conditions: Pressure Sore.

What interventions are being tested in trial NCT05598398?

The interventions under investigation include: V.A.C.Ulta™ Negative Pressure Wound Therapy System (DEVICE), Standard of Care (Wet-to-dry dressings) (OTHER).

Who is sponsoring clinical trial NCT05598398?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05598398 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.